Concepedia

Aditi Pandya Martin

AP

Statistics

Publications

7

Citations

666

H-Index

7

Active since

2008

Affiliations

Virginia Commonwealth University(Current)

University of Alabama at Birmingham

Aditi Pandya Martin is an author at Virginia Commonwealth University specializing in oncology, pharmacology, and molecular oncology.

Publications per year

2008–2010

7

Publications

7

Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation

Margaret A. Park, Guo Zhang, Aditi Pandya Martin et al. · Cancer Biology & Therapy · 2008 · 172 citations · Full text

, , +17

Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation

Guo Zhang, Margaret A. Park, Clint Mitchell et al. · Clinical Cancer Research · 2008 · 114 citations · Full text

, , +16

Inhibition of MCL-1 enhances Lapatinib toxicity and overcomes lapatinib resistance via BAK-dependent autophagy

Aditi Pandya Martin, Clint Mitchell, Mohamed Rahmani et al. · Cancer Biology & Therapy · 2009 · 97 citations

, , +17

BCL-2 Family Inhibitors Enhance Histone Deacetylase Inhibitor and Sorafenib Lethality via Autophagy and Overcome Blockade of the Extrinsic Pathway to Facilitate Killing

Aditi Pandya Martin, Margaret A. Park, Clint Mitchell et al. · Molecular Pharmacology · 2009 · 86 citations · Full text

, , +17

Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo

Clint Mitchell, Adly Yacoub, Hamed Hossein et al. · Cancer Biology & Therapy · 2010 · 76 citations · Full text

, , +17

1–5 of 7